Genomic testing in breast and ovarian cancer can be clinically useful in two main areas:
- Diagnostic testing for individuals with a diagnosis or personal history of cancer
- Predictive testing for unaffected individuals to determine the future risk of cancer, usually when there is a family history and a known gene change that runs in the family.
Awareness of inherited cancer risk can alter medical care for individuals and their families.
